Sepsis Diagnostics Market Analysis By Product (Instruments, Blood Culture Media, Assay Kits), By Technology (Microbiology, Molecular Diagnostics, Immunoassays), By Testing Type (Laboratory, PoC), By Pathogen, And Segment Forecasts, 2018 - 2025

Industry Insights

The global sepsis diagnostics market size was valued at USD 339.4 million in 2015 and is expected to witness attractive growth over the forecast period. Rising prevalence of sepsis has led to a growing need for its early diagnosis. Septic poisoning may result in severe inflammation, leading to prolonged hospitalization. This condition is also one of the leading causes of death. Hence, in order to reduce the alarming mortality rate amongst people developing septicemia, demand for related diagnostic products is expected to grow to a great extent in the near future.

Hospital-acquired infections also significantly contribute toward the growth of the market. Such infections amongst patients are a result of prolonged hospital stays. WHO estimated that the rate of ICU-acquired infections is at least 2-3 times higher in developing countries as compared to developed countries. These infections including urinary-tract and surgical site wound infections majorly lead to severe sepsis.

Global sepsis diagnostics market share, by product, 2015

Increasing number of surgical cases leading to post-operative infections cause septic shock. Post-surgical infections generally arise due to factors such as failure to sterilize the surgical site and to use sterile surgical instruments. Thus, diagnostic instruments and assays are increasingly demanded by hospitals for early detection of septic shock.

Product Insights

On the basis of product, the market is segmented into instruments, blood culture media, assay kits & reagents. In 2015, blood culture media was estimated to be the largest grossing segment and is also anticipated to be fastest growing during the forecast period. This is due to the fact that blood culture is considered as the gold standard method and cost-effective mode of testing by clinicians.

Assay kits and reagents are also expected to show lucrative growth owing to their capability of early diagnosis of sepsis as well as introduction of automated tests by major companies. On the other hand, instruments accounted for the least share in the sepsis diagnostics market in 2015.

Technology Insights

Amongst the technology segment, microbiology dominated in 2015 primarily due to the fact that it allows the quantitative detection and identification of microorganisms for sepsis diagnosis through the application of culture media tests.

UK sepsis diagnostics market, by technology, 2014-2025 (USD Million)

Molecular diagnostics segment is anticipated to show attractive growth over the forecast period. Factors attributing to growth are low turnaround time and accurate results. Such molecular diagnostic methods allow reduction in hospital stays and also aid in diminishing mortality rate of people suffering from sepsis.

Pathogen Insights

On the basis of pathogens causing septicemia, the market has been segmented into bacterial, fungal sepsis, and other viruses & parasites. Bacterial sepsis segment held the largest share in 2015 due to the fact that most of the patients suffering from blood poisoning disease are a victim of bacterial infection. The most commonly formed bacterial sepsis is gram-negative bacteria.

Fungal sepsis is projected to grow at an attractive CAGR due to the prevalence of Candida infection resulting in septic poisoning. A lesser number of viruses and parasites cause this disease, hence, this segment accounted for a very low share in the 2015.

Testing Type Insights

The laboratory segment dominated the market in 2015 owing to the rising number of blood culture tests being conducted in laboratories. However, laboratory testing leads to delay in delivering the diagnostic results, which may affect the initiation of treatment.

Point-of-Care (PoC) testing is expected to witness healthy growth over the forecast period. The introduction of technologically advanced products and increasing demand for rapid diagnostic tests are expected to support market growth.

Regional Insights

In 2015, North America dominated the market owing to the presence of a well-established healthcare infrastructure as well as the rapid adoption of advanced products. Moreover, septic poisoning is a leading cause of mortality in countries like the U.S., which is accelerating the demand for diagnostic products.

Asia Pacific is projected to exhibit lucrative growth rate over the forecast period. This region provides immense opportunities for key players through the introduction of novel sepsis diagnostic tests to reduce the increasing mortality rate among the population base.

Competitive Insights

Some of the key players in the market comprise Becton, Dickinson and Company, bioMérieux SA, Roche Diagnostics, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Cepheid Inc., Bruker Corporation, and Nanosphere, Inc.

The major companies are undertaking strategies such as mergers and acquisitions, new product development, and regional expansion for serving the unmet needs of the patients. For instance, in 2016, BioFire Diagnostics, LLC, the molecular biology counterpart of bioMérieux received U.S. FDA clearance for FilmArray Torch for use with the FilmArray Blood Culture Identification (BCID) Panel.

Sepsis Diagnostics Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the sepsis diagnostics market on the basis of product, technology, pathogen, testing type and region:

• Product Outlook (Revenue, USD Million; 2014 - 2025)

  • Instruments

  • Blood Culture Media

  • Assay Kits and Reagents

• Technology Outlook (Revenue, USD Million; 2014 - 2025)

  • Microbiology

  • Molecular Diagnostics 

  • Immunoassays

  • Flow Cytometry

• Pathogen Outlook (Revenue, USD Million; 2014 - 2025)

  • Bacterial Sepsis 

    • Gram-Positive Bacteria

    • Gram-Negative Bacteria

  • Fungal Sepsis

  • Others

• Testing Type Outlook (Revenue, USD Million; 2014 - 2025)

  • Laboratory Testing 

  • PoC Testing

• Regional Outlook (Revenue, USD Million; 2014- 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa